| [1] |
O’Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging[J]. J Natl Cancer Inst, 2004, 96(19): 1420-5.
|
| [2] |
Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM[J]. Ann Surg Oncol, 2010, 17(6): 1471-4.
|
| [3] |
AJCC cancer staging handbook[M]. 7th ed.New York: Springer, 20 10:144.
|
| [4] |
Dallas MR, Liu G, Chen WC, et al. Divergent roles of CD44 and carcinoembryonic antigen in colon cancer metastasis[J]. FASEB J, 20 12, 26(6): 2648-56.
|
| [5] |
Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999 [J]. Arch Pathol Lab Med, 2000, 124(7): 979-94.
|
| [6] |
Ratto C, Sofo L, Ippoliti M, et al. Prognostic factors in colorectal cancer.Literature review for clinical application[J]. Dis Colon Rectum, 1998, 41(8): 1033-49.
|
| [7] |
André T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer[J]. N Engl J Med, 2004, 350(23): 2343-51.
|
| [8] |
André T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fl uorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial[J]. J Clin Oncol, 20 09, 27(19): 3109-16.
|
| [9] |
Cervantes A. Preoperative chemotherapy for colon cancer is getting closer[J]. Lancet Oncol, 2012,13(11):1073-4.
|
| [10] |
Foxtrot Collaborative Group. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial[J]. Lancet Oncol, 20 12, 13(11): 1152-60.
|
| [11] |
Dighe S, Swift I, Magill L, et al. Accuracy of radiological staging in identifying high-risk colon cancer patients suitable for neoadjuvant chemotherapy: a multicentre experience[J]. Colorectal Dis, 2012, 14(4): 438-44.
|
| [12] |
Yasue H, Hanyu N, Usuba T, et al.A case successfully treated with total pelvic exenteration after preoperative chemotherapy FOLFOX4 plus bevacizumab for unresectable sigmoid colon cancer with extramural progression[J]. Gan To Kagaku Ryoho, 20 10, 37(2): 327-9.
|
| [13] |
Sun L, Wu H, Guan YS. Colonography by CT, MRI and PET/CT combined with conventional colonoscopy in colorectal cancer screening and staging[J]. World J Gastroenterol, 2008, 14(6): 85 3-63.
|
| [14] |
Jacobs JE, Boxt LM, Desjardins B, et al. ACR practice guideline for the performance and interpretation of cardiac computed tomography (CT) [J]. J Am Coll Radiol, 2006, 3(9): 677-85.
|
| [15] |
Li LR, Wan DS, Pan ZZ, et al. Prognostic effect of lymphatic metastasis of colorectal adenocarcinoma[J]. Guangdong Yi Xue, 20 06, 27(12): 1819-21. [李力人,万德森,潘志忠,等. 大肠癌淋巴 结转移对预后的影响[J]. 广东医学, 2006, 27(12): 1819-21.]
|
| [16] |
Park YJ, Park KJ, Park JG, et al. Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases[J]. World J Surg, 1999, 23(7): 721-6.
|
| [17] |
Moghimi-Dehkordi B, Safaee A, Zali MR. Prognostic factors in 1, 138 Iranian colorectal cancer patients[J]. Int J Colorectal Dis, 20 08, 23(7): 683-8.
|
| [18] |
Zhai ZW, Gu J. Infl uence of tumor size on the prognosis in patients with colon cancer[J]. Zhonghua Wei Chang Wai Ke Za Zhi, 2012, 15 (5):495-8. [翟志伟, 顾晋. 肿瘤大小对结肠癌患者预后的影响 [J] 中华胃肠外科杂志, 2012, 15(5) :495-8.]
|
| [19] |
Kanellos I, Zacharakis E, Kanellos D, et al. Prognostic signifi cance of CEA levels and detection of CEA mRNA in draining venous blood in patients with colorectal cancer[J]. J Surg Oncol, 2006, 94 (1): 3-8.
|
| [20] |
Kim SB, Fernandes LC, Saad SS, et al. Assessment of the value of preoperative serum levels of CA 242 and CEA in the staging and postoperative survival of colorectal adenocarcinoma patients[J]. Int J Biol Markers, 2003, 18(3): 182-7.
|
| [21] |
Reiter W, Stieber P, Reuter C, et al. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer[J]. Anticancer Res, 2000, 20(6D): 5195-8.
|
下载:
